CA2816242C - Signal d'incorporation de vecteurs de virus de la grippe - Google Patents

Signal d'incorporation de vecteurs de virus de la grippe Download PDF

Info

Publication number
CA2816242C
CA2816242C CA2816242A CA2816242A CA2816242C CA 2816242 C CA2816242 C CA 2816242C CA 2816242 A CA2816242 A CA 2816242A CA 2816242 A CA2816242 A CA 2816242A CA 2816242 C CA2816242 C CA 2816242C
Authority
CA
Canada
Prior art keywords
sequences
virus
vrna
incorporation
coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2816242A
Other languages
English (en)
Other versions
CA2816242A1 (fr
Inventor
Yoshihiro Kawaoka
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Priority claimed from CA2492097A external-priority patent/CA2492097C/fr
Publication of CA2816242A1 publication Critical patent/CA2816242A1/fr
Application granted granted Critical
Publication of CA2816242C publication Critical patent/CA2816242C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Linvention concerne un signal dincorporation de vecteurs de virus de la grippe ainsi que des procédés dutilisation du signal pour transmettre et maintenir des acides nucléiques de virus de la grippe et étrangers dans des virus et des cellules.
CA2816242A 2002-02-13 2003-02-12 Signal d'incorporation de vecteurs de virus de la grippe Expired - Lifetime CA2816242C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35653802P 2002-02-13 2002-02-13
US60/356,538 2002-02-13
US43867903P 2003-01-07 2003-01-07
US60/438,679 2003-01-07
CA2492097A CA2492097C (fr) 2002-02-13 2003-02-12 Signal d'incorporation de vecteurs de virus de la grippe

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2492097A Division CA2492097C (fr) 2002-02-13 2003-02-12 Signal d'incorporation de vecteurs de virus de la grippe

Publications (2)

Publication Number Publication Date
CA2816242A1 CA2816242A1 (fr) 2003-08-21
CA2816242C true CA2816242C (fr) 2019-01-08

Family

ID=38252217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2816242A Expired - Lifetime CA2816242C (fr) 2002-02-13 2003-02-12 Signal d'incorporation de vecteurs de virus de la grippe

Country Status (2)

Country Link
CN (1) CN1997734A (fr)
CA (1) CA2816242C (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180737B2 (en) 2015-08-28 2021-11-23 Wisconsin Alumni Research Foundation (Warf) Generation of infectious influenza viruses from virus-like particles
US11384339B2 (en) 2011-08-26 2022-07-12 Wisconsin Alumni Research Foundation (Warf) Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
US11802273B2 (en) 2014-06-20 2023-10-31 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
US11851648B2 (en) 2019-02-08 2023-12-26 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US12076387B2 (en) 2010-03-23 2024-09-03 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US12122807B2 (en) 2019-05-01 2024-10-22 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
US12144857B2 (en) 2018-08-20 2024-11-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
US12251436B2 (en) 2017-10-25 2025-03-18 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
US12290562B2 (en) 2020-03-25 2025-05-06 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US12365880B2 (en) 2020-01-24 2025-07-22 The University Of Tokyo Recombinant influenza viruses with stabilized NA
US12364748B2 (en) 2016-02-19 2025-07-22 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039100T2 (hu) * 2009-06-24 2018-12-28 Medicago Inc Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
CN113355292B (zh) * 2021-06-04 2024-02-06 天康制药股份有限公司 一种猪圆环病毒基因改造型弱毒株、构建方法及其应用

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12076387B2 (en) 2010-03-23 2024-09-03 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US11384339B2 (en) 2011-08-26 2022-07-12 Wisconsin Alumni Research Foundation (Warf) Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
US12410409B2 (en) 2011-08-26 2025-09-09 Wisconsin Alumni Research Foundation (Warf) Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
US11802273B2 (en) 2014-06-20 2023-10-31 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
US11180737B2 (en) 2015-08-28 2021-11-23 Wisconsin Alumni Research Foundation (Warf) Generation of infectious influenza viruses from virus-like particles
US12364748B2 (en) 2016-02-19 2025-07-22 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
US12251436B2 (en) 2017-10-25 2025-03-18 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US12144857B2 (en) 2018-08-20 2024-11-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
US11851648B2 (en) 2019-02-08 2023-12-26 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US12258557B2 (en) 2019-02-08 2025-03-25 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US12122807B2 (en) 2019-05-01 2024-10-22 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
US12365880B2 (en) 2020-01-24 2025-07-22 The University Of Tokyo Recombinant influenza viruses with stabilized NA
US12290562B2 (en) 2020-03-25 2025-05-06 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses

Also Published As

Publication number Publication date
CA2816242A1 (fr) 2003-08-21
CN1997734A (zh) 2007-07-11

Similar Documents

Publication Publication Date Title
CA2492097C (fr) Signal d'incorporation de vecteurs de virus de la grippe
US12076387B2 (en) Vaccines comprising mutant attenuated influenza viruses
US10119124B2 (en) Influenza M2 protein mutant viruses as live influenza attenuated vaccines
US7176021B2 (en) Mutant cells with altered sialic acid
CA2816242C (fr) Signal d'incorporation de vecteurs de virus de la grippe
JP4456169B2 (ja) インフルエンザウイルスベクターのパッケージングのためのシグナル

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130514

MKEX Expiry

Effective date: 20230213